Vasopressin in Asystolic Cardiac Arrest

Publisher Website
Google Scholar
Abstract
Cardiac arrest remains a major health problem in the United States and other Western nations. Of the approximately 1000 sudden deaths that occur each day in the United States, it is estimated that as many as 20 to 40 percent result from asystolic cardiac arrest.13 In this issue of the Journal, Wenzel et al.4 demonstrate the success of vasopressin alone and vasopressin followed by epinephrine in refractory asystolic cardiac arrest — an important breakthrough in the science of resuscitation. These advances should be translated into a new standard of care without delay. Medical policymakers should do whatever is necessary . . .